Clinical Trials Directory

Trials / Completed

CompletedNCT02539901

Development of a Deaf Child With a Cochlear Implant.

Cognitive and Communicative Development Description of Deaf Child With a Cochlear Implant.

Status
Completed
Phase
Study type
Observational
Enrollment
73 (actual)
Sponsor
University Hospital, Toulouse · Academic / Other
Sex
All
Age
12 Months – 9 Years
Healthy volunteers
Accepted

Summary

Cochlear implantation enables profoundly deaf children to acquire speech and develop their understanding of spoken language. However, there are significant interindividual differences in the results obtained with the implant. Given the lack of theoretical knowledge on acoustic predictors, cognitive and language to obtain optimum speech recognition with cochlear implants associated with a good communicative and language development of deaf children, the investigators intend to achieve a preliminary longitudinal study aimed to describe the cognitive, communicative and perceptive implanted deaf children. The main objective of our study is to describe the cognitive and communicative development of deaf children implanted from the pre-implant assessment to 18 months post-implantation, by addressing the following aspects: * The psychomotor and cognitive development assessed using the Brunet-Lézine test; * The development of preverbal communication, evaluated using the Early Social Communication Scale.

Conditions

Interventions

TypeNameDescription
BEHAVIORALEvaluation of the detection of non-linguistic soundsEvaluation of the detection of non-linguistic sounds (sound room)
BEHAVIORALFree hearing test categorizationFree hearing test categorization evaluation
BEHAVIORALEarly Social Communication Scale (ECSP)Early Social Communication Scale (ECSP) evaluation
BEHAVIORALpsychomotor infancy development scale
BEHAVIORALNEPSY (two domains: "memory and learning" and "attention and executive functions").NEPSY evaluation

Timeline

Start date
2011-10-01
Primary completion
2014-10-01
Completion
2014-10-01
First posted
2015-09-03
Last updated
2015-09-03

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT02539901. Inclusion in this directory is not an endorsement.